Changes in colistin resistance and mcr-1 abundance in Escherichia coli of animal and human origins following the ban of colistin-positive additives in China: an epidemiological comparative study. (2020)
Attributed to:
Determining the clinical and environmental impact, burden and cost of Extensively Drug Resistant Enterobacteriaceae in China (DETER-XDRE-CHINA-HUB)
funded by
Newton Fund
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(20)30149-3
PubMed Identifier: 32505232
Publication URI: http://europepmc.org/abstract/MED/32505232
Type: Journal Article/Review
Volume: 20
Parent Publication: The Lancet. Infectious diseases
Issue: 10
ISSN: 1473-3099